| Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 BS Sheena, L Hiebert, H Han, H Ippolito, M Abbasi-Kangevari, ... The lancet Gastroenterology & hepatology 7 (9), 796-829, 2022 | 328 | 2022 |
| Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021 GBD 2021 Anaemia Collaborators The Lancet Haematology 10 (9), e713-e734, 2023 | 64 | 2023 |
| Efficacy and safety of recently approved drugs for sickle cell disease: a review of clinical trials MA Ali, A Ahmad, H Chaudry, W Aiman, S Aamir, MY Anwar, A Khan Experimental hematology 92, 11-18. e1, 2020 | 61 | 2020 |
| Systematic review and meta-analysis of CD19-specific CAR-T cell therapy in relapsed/refractory acute lymphoblastic leukemia in the pediatric and young adult population: safety … S Aamir, MY Anwar, F Khalid, SI Khan, MA Ali, ZE Khattak Clinical Lymphoma Myeloma and Leukemia 21 (4), e334-e347, 2021 | 41 | 2021 |
| Anorexia and Cachexia T Ohnuma, MA Ali, R Adigun StatPearls, 0 | 16* | |
| Persistence of cryoglobulinemic vasculitis after DAA induced HCV cure M Danishwar, Z Jamil, S Khan, M Nakhla, I Ahmad, MA Ali, DTY Lau Journal of Clinical Medicine 11 (4), 984, 2022 | 15 | 2022 |
| Follicular lymphoma H Kaseb, MA Ali, DP Gasalberti, NV Koshy StatPearls [internet], 2024 | 14 | 2024 |
| Novel therapies of hepatitis B and D IW Khan, MU Dad Ullah, M Choudhry, MJ Ali, MA Ali, SLK Lam, PA Shah, ... Microorganisms 9 (12), 2607, 2021 | 12 | 2021 |
| Efficacy and safety of pembrolizumab based therapies in triple-negative breast cancer: A systematic review of clinical trials MA Ali, W Aiman, SS Shah, M Hussain, R Kashyap Critical Reviews in Oncology/Hematology 157, 103197, 2021 | 10 | 2021 |
| Efficacy and tolerability of isocitrate dehydrogenase inhibitors in patients with acute myeloid leukemia: a systematic review of clinical trials W Aiman, MA Ali, MA Basit, Z Omar, M Suleman, M Hassan, T Jamil, ... Leukemia Research, 107077, 2023 | 8 | 2023 |
| Efficacy and safety of oral GnRh antagonists in patients with uterine fibroids: a systematic review R Niaz, M Saeed, H Khan, MA Ali, A Irshad, M Faiz, A Irshad, F Fatima, ... Journal of Obstetrics and Gynaecology Canada 44 (12), 1279-1288, 2022 | 7 | 2022 |
| Safety and efficacy of tyrosine kinase inhibitors in immune thrombocytopenic purpura: a systematic review of clinical trials MA Ali, MY Anwar, W Aiman, G Dhanesar, Z Omar, M Hamza, M Zafar, ... Journal of Xenobiotics 13 (1), 29-41, 2023 | 5 | 2023 |
| MM-082 Addition of Daratumumab to Drug Regimens in the Treatment of Multiple Myeloma: A Systematic Review and Meta-Analysis of Randomized Clinical Trials W Aiman, A Anwar, DI Satti, M Hamza, AM Perez, AA Khan, A Nepal, ... Clinical Lymphoma Myeloma and Leukemia 22, S405, 2022 | 5 | 2022 |
| Delays in breast cancer diagnosis at a tertiary care facility in karachi, Pakistan M Hussain, Z Hasan, MA Ali, Z Tapal, F Saeed, W Aiman J Ayub Med Coll Abbottabad 33 (2), 248-251, 2021 | 5 | 2021 |
| Efficacy and toxicity of surufatinib in neuroendocrine tumors: A systematic review and meta‐analysis MA Ali, SS Shah, N Tahir, S Rehman, M Saeed, SF Bajwa, R Ali, W Aiman, ... Journal of Neuroendocrinology 34 (7), e13149, 2022 | 3 | 2022 |
| Current status of monoclonal antibodies-based therapies in castration-resistant prostate cancer: a systematic review and meta-analysis of clinical trials TA Tarrar, MY Anwar, MA Ali, M Saeed, S Rehman, SF Bajwa, T Ayub, ... Cureus 14 (3), 2022 | 3 | 2022 |
| Efficacy and Safety of Checkpoint Inhibitors in Clear Cell Renal Cell Carcinoma: A Systematic Review of Clinical Trials MA Ali Hematology/Oncology and Stem Cell Therapy 16 (3), 2, 2022 | 3 | 2022 |
| Efficacy and Safety of RET-Specific Kinase Inhibitors in RET-Altered Cancers: A Systematic Review MA Ali, SS Shah, R Ali, SF Bajwa, S Rehman, A Anwar, MY Anwar, ... Cancer Investigation 41 (8), 739-749, 2023 | 2 | 2023 |
| Efficacy and safety of viral vector based gene therapy in patients with hemophilia a: a systematic review W Aiman, SH Kazmi, M Saeed, MI Khan, Z Omar, M Suleman, T Jamil, ... Blood 140 (Supplement 1), 12992-12993, 2022 | 2 | 2022 |
| Efficacy and safety of IDH inhibitors in AML: a systematic review of clinical trials MA Ali, S Fatima, A Nepal, H Khan, MK Bhatti, M Saeed, R Niaz, R Habib, ... Blood 140 (Supplement 1), 11763-11764, 2022 | 2 | 2022 |
Wajeeha AimanSaint Michael's Medical Center在 primehealthcare.com 的电子邮件经过验证
